Nandakumar Nagaraja1, Amreen Farooqui2, Abdullah Bin Zahid2, Supreet Kaur3. 1. Department of Neurology, University of Florida College of Medicine, Gainesville, FL, USA. Electronic address: nandakumar.nagaraja@neurology.ufl.edu. 2. Department of Neurology, University of Florida College of Medicine, Gainesville, FL, USA. 3. Department of Neurology, Barrow Neurological Institute, Phoenix, AZ, USA.
Abstract
OBJECTIVES: Cerebral microbleeds (CMB) are associated with increased risk of hemorrhagic transformation (HT) of ischemic stroke with alteplase. Whether the presence of CMB influences the risk of HT and discharge outcomes of stroke patients not receiving alteplase is unclear. We evaluated the factors associated with the presence of CMB, and if the rates of HT and discharge outcomes were modified by the presence of CMB among stroke patients not treated with alteplase. METHODS: Ischemic stroke patients who had MRI and did not receive alteplase were included in the study. CMB, HT and white matter hyperintensity (WMH) were evaluated using Microbleed Anatomical Rating Scale, Heidelberg bleeding classification, and Fazekas scales, respectively. Multivariate regression analysis was performed to evaluate factors associated with the presence of CMB. RESULTS: Among 196 patients in the study, 58 (30%) patients had CMB. Nine patients had ≥ 10 CMBs. Median National Institutes of Health stroke scale score was 4. In multivariate analysis, age (OR=1.07;95%CI=1.01-1.12), history of stroke (OR=3.10;95%CI=1.08-8.92), congestive heart failure (OR=7.26;95%CI=1.58-33.42), admission diastolic blood pressure (OR=1.03;95%CI=1.003-1.06) and severe WMH defined as Fazekas score 4-6 (OR=4.69;95%CI=1.80-12.23) were significantly associated with the presence of CMB. There was no difference in HT (10% vs 12%, p = 0.80) or discharge outcomes (modified Rankin Scale 0-2: 53% vs 57%, p = 0.62) of patients with CMB compared to those without CMB. CONCLUSION: CMB are associated with severe WMH and higher diastolic blood pressure. CMB are not associated with the HT occurrence or discharge outcome of mild ischemic stroke in the absence of alteplase.
OBJECTIVES: Cerebral microbleeds (CMB) are associated with increased risk of hemorrhagic transformation (HT) of ischemic stroke with alteplase. Whether the presence of CMB influences the risk of HT and discharge outcomes of stroke patients not receiving alteplase is unclear. We evaluated the factors associated with the presence of CMB, and if the rates of HT and discharge outcomes were modified by the presence of CMB among stroke patients not treated with alteplase. METHODS: Ischemic stroke patients who had MRI and did not receive alteplase were included in the study. CMB, HT and white matter hyperintensity (WMH) were evaluated using Microbleed Anatomical Rating Scale, Heidelberg bleeding classification, and Fazekas scales, respectively. Multivariate regression analysis was performed to evaluate factors associated with the presence of CMB. RESULTS: Among 196 patients in the study, 58 (30%) patients had CMB. Nine patients had ≥ 10 CMBs. Median National Institutes of Health stroke scale score was 4. In multivariate analysis, age (OR=1.07;95%CI=1.01-1.12), history of stroke (OR=3.10;95%CI=1.08-8.92), congestive heart failure (OR=7.26;95%CI=1.58-33.42), admission diastolic blood pressure (OR=1.03;95%CI=1.003-1.06) and severe WMH defined as Fazekas score 4-6 (OR=4.69;95%CI=1.80-12.23) were significantly associated with the presence of CMB. There was no difference in HT (10% vs 12%, p = 0.80) or discharge outcomes (modified Rankin Scale 0-2: 53% vs 57%, p = 0.62) of patients with CMB compared to those without CMB. CONCLUSION: CMB are associated with severe WMH and higher diastolic blood pressure. CMB are not associated with the HT occurrence or discharge outcome of mild ischemic stroke in the absence of alteplase.
Authors: P Kapeller; R Barber; R J Vermeulen; H Adèr; P Scheltens; W Freidl; O Almkvist; M Moretti; T del Ser; P Vaghfeldt; C Enzinger; F Barkhof; D Inzitari; T Erkinjunti; R Schmidt; F Fazekas Journal: Stroke Date: 2003-02 Impact factor: 7.914
Authors: Saloua Akoudad; Frank J Wolters; Anand Viswanathan; Renée F de Bruijn; Aad van der Lugt; Albert Hofman; Peter J Koudstaal; M Arfan Ikram; Meike W Vernooij Journal: JAMA Neurol Date: 2016-08-01 Impact factor: 18.302
Authors: Georgios Tsivgoulis; Ramin Zand; Aristeidis H Katsanos; Guillaume Turc; Christian H Nolte; Simon Jung; Charlotte Cordonnier; Jochen B Fiebach; Jan F Scheitz; Pascal P Klinger-Gratz; Catherine Oppenheim; Nitin Goyal; Apostolos Safouris; Heinrich P Mattle; Anne W Alexandrov; Peter D Schellinger; Andrei V Alexandrov Journal: JAMA Neurol Date: 2016-06-01 Impact factor: 18.302
Authors: Mariëlle M F Poels; M Arfan Ikram; Aad van der Lugt; Albert Hofman; Gabriel P Krestin; Monique M B Breteler; Meike W Vernooij Journal: Stroke Date: 2011-02-09 Impact factor: 7.914
Authors: Andreas Charidimou; Guillaume Turc; Catherine Oppenheim; Shenqiang Yan; Jan F Scheitz; Hebun Erdur; Pascal P Klinger-Gratz; Marwan El-Koussy; Wakoh Takahashi; Yusuke Moriya; Duncan Wilson; Chelsea S Kidwell; Jeffrey L Saver; Asma Sallem; Solene Moulin; Myriam Edjlali-Goujon; Vincent Thijs; Zoe Fox; Ashkan Shoamanesh; Gregory W Albers; Heinrich P Mattle; Oscar R Benavente; H Rolf Jäger; Gareth Ambler; Junya Aoki; Jean-Claude Baron; Kazumi Kimura; Wataru Kakuda; Shunya Takizawa; Simon Jung; Christian H Nolte; Min Lou; Charlotte Cordonnier; David J Werring Journal: Stroke Date: 2017-08 Impact factor: 7.914
Authors: M W Vernooij; A van der Lugt; M A Ikram; P A Wielopolski; W J Niessen; A Hofman; G P Krestin; M M B Breteler Journal: Neurology Date: 2008-04-01 Impact factor: 9.910
Authors: Duncan Wilson; Gareth Ambler; Keon-Joo Lee; Jae-Sung Lim; Masayuki Shiozawa; Masatoshi Koga; Linxin Li; Caroline Lovelock; Hugues Chabriat; Michael Hennerici; Yuen Kwun Wong; Henry Ka Fung Mak; Luis Prats-Sánchez; Alejandro Martínez-Domeño; Shigeru Inamura; Kazuhisa Yoshifuji; Ethem Murat Arsava; Solveig Horstmann; Jan Purrucker; Bonnie Yin Ka Lam; Adrian Wong; Young Dae Kim; Tae-Jin Song; Maarten Schrooten; Robin Lemmens; Sebastian Eppinger; Thomas Gattringer; Ender Uysal; Zeynep Tanriverdi; Natan M Bornstein; Einor Ben Assayag; Hen Hallevi; Jun Tanaka; Hideo Hara; Shelagh B Coutts; Lisa Hert; Alexandros Polymeris; David J Seiffge; Philippe Lyrer; Ale Algra; Jaap Kappelle; Rustam Al-Shahi Salman; Hans R Jäger; Gregory Y H Lip; Heinrich P Mattle; Leonidas D Panos; Jean-Louis Mas; Laurence Legrand; Christopher Karayiannis; Thanh Phan; Sarah Gunkel; Nicolas Christ; Jill Abrigo; Thomas Leung; Winnie Chu; Francesca Chappell; Stephen Makin; Derek Hayden; David J Williams; M Eline Kooi; Dianne H K van Dam-Nolen; Carmen Barbato; Simone Browning; Kim Wiegertjes; Anil M Tuladhar; Noortje Maaijwee; Christine Guevarra; Chathuri Yatawara; Anne-Marie Mendyk; Christine Delmaire; Sebastian Köhler; Robert van Oostenbrugge; Ying Zhou; Chao Xu; Saima Hilal; Bibek Gyanwali; Christopher Chen; Min Lou; Julie Staals; Régis Bordet; Nagaendran Kandiah; Frank-Erik de Leeuw; Robert Simister; Aad van der Lugt; Peter J Kelly; Joanna M Wardlaw; Yannie Soo; Felix Fluri; Velandai Srikanth; David Calvet; Simon Jung; Vincent I H Kwa; Stefan T Engelter; Nils Peters; Eric E Smith; Yusuke Yakushiji; Dilek Necioglu Orken; Franz Fazekas; Vincent Thijs; Ji Hoe Heo; Vincent Mok; Roland Veltkamp; Hakan Ay; Toshio Imaizumi; Beatriz Gomez-Anson; Kui Kai Lau; Eric Jouvent; Peter M Rothwell; Kazunori Toyoda; Hee-Joon Bae; Joan Marti-Fabregas; David J Werring Journal: Lancet Neurol Date: 2019-05-23 Impact factor: 59.935
Authors: Adam Nyul-Toth; Gabor A Fulop; Stefano Tarantini; Tamas Kiss; Chetan Ahire; Janet A Faakye; Anna Ungvari; Peter Toth; Attila Toth; Anna Csiszar; Zoltan Ungvari Journal: Geroscience Date: 2022-01-06 Impact factor: 7.581